HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis

被引:30
作者
Klein, MR
Smith, SM
Hammond, AS
Ogg, GS
King, AS
Vekemans, J
Jaye, A
Lukey, PT
McAdam, KPWJ
机构
[1] MRC Labs, TB Res Programme, Fajara, Gambia
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Immunol Unit, London WC1, England
[3] Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
[4] GlaxoSmithKline Res & Dev Ltd, Resp Syst, Stevenage, Herts, England
基金
英国医学研究理事会;
关键词
D O I
10.1086/319267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Few target epitopes have been described for human CD8 T lymphocytes in antigens of Mycobacterium tuberculosis. By use of a reverse immunogenetics approach, 23 motif-bearing peptides of the Ag85 complex were tested for binding to HLA-B*35, one of the common B-types in West Africa. Three 9-mer peptides bound with high affinity to HLA-B*3501 and displayed low dissociation rates of peptide-major histocompatibility complexes (MHCs). IC50 and half-life values of peptide-MHC class I complexes were in the same range as reported earlier for other immunogenic peptides. Immune responses against peptide Ag85C (aa 204-212) WPTLIGLAM were characterized in detail. Peptide-stimulated effector cells were able to kill macrophages infected with M. tuberculosis or bacille Calmette-Guerin. Peptide-specific CD8 T cells could be visualized by using HLA-B*3501 tetramers and were shown to produce interferon-gamma and tumor necrosis factor-alpha. Together with other published epitopes, these peptides can be used to study more closely the role of CD8 T cells in mycobacterial infection and tuberculosis.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 45 条
[1]  
ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411
[2]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[3]  
BLEED D, 2000, WHOCDSTB2000275
[4]   Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice [J].
Bonato, VLD ;
Lima, VMF ;
Tascon, RE ;
Lowrie, DB ;
Silva, CL .
INFECTION AND IMMUNITY, 1998, 66 (01) :169-175
[5]   Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].
Bunce, M ;
ONeill, CM ;
Barnardo, MCNM ;
Krausa, P ;
Browning, MJ ;
Morris, PJ ;
Welsh, KI .
TISSUE ANTIGENS, 1995, 46 (05) :355-367
[6]  
Canaday DH, 1999, J IMMUNOL, V162, P372
[7]   Antimicrobial activity of MHC class I-restricted CD8+T cells in human tuberculosis [J].
Cho, S ;
Mehra, V ;
Thoma-Uszynski, S ;
Stenger, S ;
Serbina, N ;
Mazzaccaro, RJ ;
Flynn, JL ;
Barnes, PF ;
Southwood, S ;
Celis, E ;
Bloom, BR ;
Modlin, RL ;
Sette, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12210-12215
[8]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[9]   An interactive web site providing major histocompatibility ligand predictions: Application to HIV research [J].
DeGroot, AS ;
Jesdale, BM ;
Szu, E ;
Schafer, JR ;
Chicz, RM ;
Deocampo, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (07) :529-531
[10]   Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection [J].
Denis, O ;
Tanghe, A ;
Palfliet, K ;
Jurion, F ;
van den Berg, TP ;
Vanonckelen, A ;
Ooms, J ;
Saman, E ;
Ulmer, JB ;
Content, J ;
Huygen, K .
INFECTION AND IMMUNITY, 1998, 66 (04) :1527-1533